Page contentsPage contents Key facts Decision Key facts Active substance Botulinum toxin type A Therapeutic area Skin and subcutaneous tissue disorders Decision number EMA/PE/0000232171 PIP number EMA/PE/0000232171 Pharmaceutical form(s) All pharmaceutical forms Condition(s) / indication(s) Treatment of skin wrinkling Route(s) of administration All routes of administration Contact for public enquiries Relife S.r.l. Tel. +39 3488566326 E-mail: acorvo@relifecompany.it Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 20/03/2025 Compliance check done No Decision EMA/PE/0000232171 : EMA decision of 20 March 2025 on the granting of a product specific waiver for botulinum toxin type AAdopted Reference Number: EMADOC-1700519818-1976392 English (EN) (219.84 KB - PDF)First published: 04/06/2026 View Share this page